Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Akt inhibitor.
Tuberculosis antigen
Tetracycline; protein translation inhibitor, po...
Natural steroid hormone produced by arthropods;...
Aminoglycoside; protein translation inhibitor, ...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Endogenous peptide hormone, counteracts insulin...
Quinolone, antioxidant.
β-lactam; penicillin binding protein inhibitor...
Antimicrobial peptide.
Synthetic ITC.
Peptide produced in tomato leaves; potential ca...
Acyl-CoA synthetase inhibitor.
Steroid hormone involved in stress signaling; g...
Phenylpropanoid found in Castilleja, Verbena, V...
Mycotoxin produced by species of Aspergillus; D...
Tenoxicam impurity
Tocopherol analog
Tetracycline; protein translation inhibitor, MM...
Neuromodulator, biomarker